Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by M Török and Mark Toshner.
M Török
Connection Strength
1.260
Mark Toshner
  1. How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis. BMJ Open. 2020 10 05; 10(10):e044566.
    View in: PubMed
    Score: 0.906
  2. Challenges and opportunities for conducting a vaccine trial during the COVID-19 pandemic in the United Kingdom. Clin Trials. 2021 10; 18(5):615-621.
    View in: PubMed
    Score: 0.238
  3. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 03 06; 397(10277):881-891.
    View in: PubMed
    Score: 0.058
  4. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 01 09; 397(10269):99-111.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.